ClinConnect ClinConnect Logo
Search / Trial NCT06094478

Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition

Launched by UNIVERSITY OF CHICAGO · Oct 17, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Interhospital Transfer Quality Improvement Implementation Science Stroke Systems Of Care

ClinConnect Summary

This clinical trial is looking at how hospitals can better and faster evaluate patients who may be having a stroke. When someone has a stroke, they are often taken to the nearest hospital, but sometimes they need to be transferred to a different hospital that offers more advanced care. The study aims to improve the process of quickly assessing stroke patients and deciding who needs to be transferred, ensuring they receive the specialized treatments they need without unnecessary delays.

To participate in this trial, individuals must be at least 18 years old and diagnosed with specific types of strokes, such as acute ischemic stroke or hemorrhagic stroke. Unfortunately, those under 18, those with certain other conditions, or those who leave the hospital against medical advice cannot join. Participants will help hospitals learn how to implement better care protocols for stroke patients, and they can expect to be part of a process that aims to improve treatment outcomes for future patients. This study is currently recruiting participants, and it’s an opportunity to contribute to important research in stroke care.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age \>=18 years
  • Final diagnosis: AIS, ICH, or SAH
  • Exclusion Criteria:
  • Final diagnosis: TIA or stroke NOS
  • Age \<18 years
  • Comfort care measures on day 0 or 1
  • Left hospital against medical advice
  • Enrolled in clinical trial related to stroke that is competing with this study

About University Of Chicago

The University of Chicago is a prestigious research institution renowned for its commitment to advancing medical science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, the University actively engages in cutting-edge research across various therapeutic areas. Its dedicated team of experienced investigators and state-of-the-art facilities enable the University of Chicago to conduct rigorous clinical studies aimed at improving patient outcomes and translating scientific discoveries into tangible healthcare solutions. The institution prioritizes ethical standards and patient safety, ensuring that all trials adhere to the highest regulatory guidelines and best practices in clinical research.

Locations

Miami, Florida, United States

Cincinnati, Ohio, United States

New Haven, Connecticut, United States

Salt Lake City, Utah, United States

New York, New York, United States

Patients applied

0 patients applied

Trial Officials

Shyam Prabhakaran, MD, MS

Principal Investigator

University of Chicago

Jane Holl, MD, MPH

Principal Investigator

University of Chicago

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported